Clinical Cardiology Alert – April 1, 2011
April 1, 2011
View Issues
-
Predicting Left Main and Triple-vessel Disease in ACS
Patients presenting with acute coronary syndromes (ACS) should be administered dual anti-platelet therapy with aspirin and a thienopyridine, such as clopidogrel. However, some patients are subsequently found to have left main (LM) or multivessel disease (MVD) and require coronary artery bypass graft (CABG) surgery. For patients who have been loaded with clopidogrel, early CABG can result in excess bleeding: -
ASD Closure in Older Adults
Atrial septal defects (asd) are the most frequent congenital heart defects. Closure of the defect (either surgically or percutaneously) is a Class 1 recommendation in the ACC/AHA guidelines for management of adults with congenital heart disease when there is right heart dilation. -
Left Atrial Septal Pouch and Stroke
The source of embolic thrombotic material in patients with cryptogenic stroke is controversial. -
LV-assist Device: Bridge to Myocardial Recovery?
The heartmate ii left ventricular assist device (LVAD) is a continuous flow device compared to the pulsatile flow Heartmate I. -
Estimating Stroke Risk in Atrial Fibrillation
In this paper, daccarett and colleagues from the University of Utah assessed the potential contribution of cardiac magnetic resonance imaging for detection of left atrial fibrosis to risk stratify patients for stroke with atrial fibrillation. -
Sex Differences in CRT-D for Class I-II Heart Failure
The madit-crt trial compared the effects of implanting defibrillators with and without resynchronization therapy in patients with New York Heart Association (NYHA) functional class I and II heart failure symptoms, -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.